Skip to main content
Journal of Translational Medicine logoLink to Journal of Translational Medicine
. 2021 Oct 4;19:414. doi: 10.1186/s12967-021-02866-7

Correction to: Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers

Dobrin D Draganov 1,, Antonio F Santidrian 1, Ivelina Minev 1, Duong Nguyen 1, Mehmet Okyay Kilinc 1, Ivan Petrov 2, Anna Vyalkova 2, Elliot Lander 4, Mark Berman 4, Boris Minev 1,3, Aladar A Szalay 1,2,3,
PMCID: PMC8489066  PMID: 34607595

Correction to: J Transl Med (2019) 17:100 https://doi.org/10.1186/s12967-019-1829-z

The authors declare that a patent application entitled “Cell-based vehicles for potentiation of viral therapy” has been filed on August 8, 2019 by the inventors Dobrin Draganov and Aladar A. Szalay [1].

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Dobrin D. Draganov, Email: ddraganov@calidibio.com

Aladar A. Szalay, Email: szalay@biozentrum.uni-wuerzburg.de, Email: aszalay@aol.com

Reference

  • 1.Draganov DD, Santidrian A, Minev I, et al. Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers. J Transl Med. 2019;17:100. doi: 10.1186/s12967-019-1829-z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Translational Medicine are provided here courtesy of BMC

RESOURCES